You are here

  • Home
  • Archive
  • Volume 5, Issue 2
  • Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in ‘high-risk’ epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade)

Article info

Article menu
Download PDFPDF
Original Articles
Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in ‘high-risk’ epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade)

Authors

  1. Address for correspondence: Dr P. J. Hoskins, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, Canada V5V 4E6.

Citation

HOSKINS PJ, SWENERTON KD, WONG F, et al
Platinum plus cyclophosphamide plus radiotherapy is superior to platinum alone in ‘high-risk’ epithelial ovarian cancer (residual negative and either stage I or II, grade 3, or stage III, any grade)
International Journal of Gynecologic Cancer 1995;5:134-142.

Publication history

  • First published March 1, 1995.
Online issue publication 
February 26, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

International Gynecologic Cancer Society